Yeshiva College Sophomore Alex Kushnir of Monsey, NY, Participates in Heart Disease Conference in Israel

Yeshiva University sophomore Alex Kushnir participated in a major conference of leading scientists and doctors in October in Eilat, Israel, of the International Academic Friends of Israel (IAFI). Co-sponsoring the conference, “Frontiers of Cardiovascular Science,” were Columbia University, The Cardiovascular Foundation, and the Israel Atherosclerosis Society.

Einstein Researcher to Receive $8 Million in NIH Funding for AIDS Research

A team of investigators from the Albert Einstein College of Medicine and Montefiore Medical Center (MMC), led by Dr. Harris Goldstein, director of Einstein’s Center for AIDS Research, will receive $1.5 million in the next year (and nearly $8 million over 5 years) from the U.S. National Institutes of Health (NIH) to support and expand the Center for AIDS Research at Einstein and MMC. The Einstein/MMC Center for AIDS Research joins an elite group of 20 other national Centers for AIDS Research designated and funded by the Centers for AIDS Research Program at the NIH.

Einstein Scientist Receives $400,000 Research Grant

Dr. David Fidock, assistant professor of microbiology and immunology at the Albert Einstein College of Medicine, is one of just eight scientists nationally to receive a 2003 Investigator in Pathogenesis Disease Award from the Burroughs Wellcome Fund. The grant, which includes $400,000 in funding over the next five years, supports and encourages aggressive, multidisciplinary approaches to investigating pathogenesis (disease development). The recipients of the award are scientists who are working on understanding the interaction between the human host and infectious agents that may be bacterial, viral, fungal, or parasitic in nature.

Einstein Researchers Help Unlock Secret to the Success of the Tuberculosis Vaccine

In a finding that could lead to better methods for preventing tuberculosis, researchers at the Albert Einstein College of Medicine have helped to solve a nearly century-old medical mystery: What caused the bacteria in the TB vaccine to become weakened and therefore safe for human use? Their findings, published in the October 14th issue of the Proceedings of the National Academy of Sciences, could lead to a better vaccine for treating TB, which kills an estimated two million to three million people worldwide each year. Dr. William Jacobs, the study’s senior author, is a Howard Hughes investigator and professor of microbiology and immunology at Einstein.

Einstein Researchers, in Jama Report, Identify Gene Connected to Human Aging and Exceptional Longevity

Researchers at the Albert Einstein College of Medicine and colleagues have discovered that a gene mutation helps people live exceptionally long lives and apparently can be passed from one generation to the next. The scientists, led by Dr. Nir Barzilai, director of the Institute for Aging Research at Einstein, report their findings in the October 15, 2003 issue of the Journal of the American Medical Association (JAMA).

YU Professor Publishes Ninth Book: Taking Stock: A Spiritual Guide to Rising Above Life’s Financial Ups and Downs

How can faith heal a depleted retirement fund and a depressed soul? After losing his money following the stock market boom of the 1990s, Rabbi Benjamin Blech, professor of Talmud at Yeshiva University (YU), questions the adage that money makes the world go ‘round in his forthcoming book, Taking Stock: A Spiritual Guide to Rising Above Life’s Financial Ups and Downs (American Management Association) to be released October 21.